Arava

Company: Hoechst Marion Roussel
Approval Status: Approved September 1998
Treatment for: Rheumatoid Arthritis
Areas: Diabetes / Endocrinology; Rheumatology

| General Information |

General Information

Arava is indicated in adults for the treatment of active rheumatoid arthritis (RA) to reduce signs and symptoms and to retard structural damage as evidenced by X-ray erosions and joint space narrowing.

< back to top

Arava Drug Information

The Arava drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.